Biogen

Biogen is a biotechnology company engaged in the development of innovative therapies for neurological and neurodegenerative diseases. Biogen is developing a pipeline of possible medicines in neurology, neuropsychiatry, specialized immunology, and rare illness, and the company is laser-focused on its mission of helping humanity through science and building a healthier, more sustainable, and equitable world.

<div>  <p>    Biogen is a biotechnology company engaged in the development of innovative therapies for neurological and neurodegenerative diseases. Founded in 1979, the company is headquartered in Cambridge, Massachusetts, United States.  </p></div>

Biogen and Neomorph Announce Multi-Target Research Collab...

Leveraging personal data for custom-fit diagnosis and treatment

Precision Medicine

INCUMBENTS_PRESENT

PROMINENT_CATEGORY

<div>
 
 <p>GeneDx has launched its Patient Access Program for pediatric epilepsy in partnership with Biogen, Praxis Precision Medicines, and Stoke Therapeutics. This program aims to increase access to exome testing for pediatric patients with epilepsy.</p>
 <p>The Patient Access Program is designed to address the limited availability of definitive genetic diagnosis in pediatric epilepsy and provide equitable care for this population. GeneDx states that the program will facilitate quicker and more precise genetic diagnoses for pediatric epilepsy patients. Additionally, the genetic data obtained from the exome testing will augment GeneDx's existing database of rare diseases. This will aid in the development of personalized treatments and therapies for epileptic seizures.</p>
 
</div>

Biogen

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless